Showing results (191-200 of 278) with videos related to
Sort By:
Pageof 28
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2011
Phase I trial of ALT-801, an interleukin-2/T-cell receptor fusion protein targeting p53 (aa264-272)/HLA-A*0201 complex, in patients with advanced malignanciesMayer N Fishman, John A Thompson, Gregory K Pennock, et al.Cancer Immunology Research|July 5, 2014
Adjuvant vaccine immunotherapy of resected, clinically node-negative melanoma: long-term outcome and impact of HLA class I antigen expression on overall survivalWilliam E Carson, Joseph M Unger, Jeffrey A Sosman, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2010
Vaccination of metastatic renal cancer patients with MVA-5T4: a randomized, double-blind, placebo-controlled phase III studyRobert J Amato, Robert E Hawkins, Howard L Kaufman, et al.Cancer|March 1, 2014
A phase 2, single-arm study of ramucirumab in patients with metastatic renal cell carcinoma with disease progression on or intolerance to tyrosine kinase inhibitor therapyJorge A Garcia, Gary R Hudes, Toni K Choueiri, et al.Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|December 20, 2024
Sleep spindle variation in patients with Parkinson's disease on first nights of sub-optimal deep brain stimulationRig Das, Stephen V Gliske, Dulce Maroni, et al.Future Oncology (London, England)|January 5, 2021
Predictive lifestyle markers for efficacy of cancer immune checkpoint inhibitors: a commentaryArthur Sillah, Scott S Tykodi, Evan T Hall, et al.American Journal of Clinical Oncology|December 19, 2009
A phase II trial of imatinib mesylate in merkel cell carcinoma (neuroendocrine carcinoma of the skin): A Southwest Oncology Group study (S0331)Wolfram E Samlowski, James Moon, Ralph J Tuthill, et al.Addictive Behaviors Reports|June 1, 2026
Recruitment feasibility for deep brain stimulation compared to transcranial magnetic stimulation treatment trials for methamphetamine use disorderJoseph Sakai, Jody Tanabe, Kristen Raymond, et al.Journal of Cancer Research and Clinical Oncology|May 17, 2023
Sclerosing mesenteritis following immune checkpoint inhibitor therapyAndrew G Kuang, Gabriel Sperling, Tom Z Liang, et al.The Journal of Clinical Investigation|January 24, 2018
Tumor-infiltrating BRAFV600E-specific CD4+ T cells correlated with complete clinical response in melanomaJoshua R Veatch, Sylvia M Lee, Matthew Fitzgibbon, et al.Pageof 28